Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function

NCT01280344 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Dysmotility

Interventions

DRUG: Saline Solution for Injection
DRUG: Ipamorelin

Sponsor

Helsinn Therapeutics (U.S.), Inc